Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 3370

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT07503340
Operetta III — A Study to Evaluate Pharmacokinetics, Safety, Tolerabili…
Ocrelizumab Co-formulated With rH… SEP Phase 3 NOT_YET_RECRUITING En attente / non publié Hoffmann-La Roche Non communiqué 2026-10-30 → 2031-08-01 Ouvrir
NCT07687693
Simultaneous T2-FLAIR and T1 Brain MRI With ENRAGED FLAIR in Multiple S…
Simultaneous T2-FLAIR and T1 Brai… SEP Non applicable COMPLETED En attente / non publié Region Stockholm Sweden · Karolinska Universitetssjukhuset, Stockholm,… 2026-08-10 → 2026-08-31 Ouvrir
NCT06743776
SEANOBI-ALS — Scalable Expanded Access With Analysis of Neurofilament a…
MN-166 Sclérose latérale amyotrophique À vérifier NO_LONGER_AVAILABLE En attente / non publié Mayo Clinic United States · Augusta University, Augusta, United S… Non communiqué Ouvrir
NCT06824961
LUCASVP — Does Increasing the Compression Pause From 3 to 5 Seconds in …
LUCASVP — Does Increasing the Com… Sclérose latérale amyotrophique Non applicable RECRUITING En attente / non publié Amsterdam UMC, location VUmc Netherlands · Ambulance Amsterdam, Amsterdam, Netherl… 2026-01-15 → 2027-07 Ouvrir
NCT05602142
Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglia…
[11C]CPPC PET ligand Sclérose latérale amyotrophique Phase 1/2 NOT_YET_RECRUITING En attente / non publié Johns Hopkins University Non communiqué 2026-11 → 2027-07 Ouvrir
NCT07224269
TZ-ALS — Effect of Terazosin on ATP Levels in People With Amyotrophic L…
Terazosine Sclérose latérale amyotrophique Phase 1 RECRUITING En attente / non publié University of Iowa United States · University of Iowa Health Care, Iowa … 2026-08-12 → 2027-10-31 Ouvrir
NCT04220021
Safety and Therapeutic Potential of the FDA-approved Drug Metformin for…
Metformin Sclérose latérale amyotrophique Phase 2 ACTIVE_NOT_RECRUITING En attente / non publié University of Florida United States · UF Health at the University of Florid… 2020-01-10 → 2027-08-31 Ouvrir
NCT05151471
Efficacy and Safety Extension Study of Oral Edaravone Administered in S…
MT-1186 Sclérose latérale amyotrophique Phase 3 TERMINATED En attente / non publié Shionogi United States, Canada, Germany, Japan, South Korea, S… 2022-01-11 → 2023-09-29 Ouvrir
NCT03567213
Investigation on the Cortical Communication (CortiCom) System
Surgical implantation of CortiCom… Sclérose latérale amyotrophique Non applicable RECRUITING En attente / non publié Johns Hopkins University United States · Johns Hopkins Medicine, Baltimore, Un… 2021-12-14 → 2030-12-31 Ouvrir
NCT05281484
Three Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01, CNMAu8…
CNM-Au8 Sclérose latérale amyotrophique À vérifier AVAILABLE En attente / non publié Clene Nanomedicine United States · Barrow Neurological Institute (Enroll… Non communiqué Ouvrir
NCT06891716
[18F]ACI-19626 PET in TDP-43 Proteinopathies
[18F]ACI-19626 PET in TDP-43 Prot… Sclérose latérale amyotrophique Phase 1 RECRUITING En attente / non publié AC Immune SA Netherlands · Amsterdam UMC, Amsterdam, Netherlands 2025-01-21 → 2026-11 Ouvrir
NCT07002034
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Ot…
RE104 for Injection Sclérose latérale amyotrophique Phase 2 RECRUITING En attente / non publié Reunion Neuroscience Inc United States · Alliance for Multispecialty Research … 2025-07-30 → 2026-12 Ouvrir
NCT05474235
Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerat…
Studies in Amyotrophic Lateral Sc… Sclérose latérale amyotrophique À vérifier RECRUITING En attente / non publié Mayo Clinic United States · Mayo Clinic Florida, Jacksonville, Un… 2007-12 → 2038-12 Ouvrir
NCT06856850
SPECTRALS — Disease Biosignatures in ALS/FTD Spectrum: New Impactful Bi…
SPECTRALS — Disease Biosignatures… Sclérose latérale amyotrophique À vérifier ACTIVE_NOT_RECRUITING En attente / non publié Fondazione I.R.C.C.S. Istituto Ne… Italy · Azienda Ospedaliero Universitaria di Sassari,… 2025-02-27 → 2027-02 Ouvrir
NCT04124965
A Study to Investigate the Long-term Safety, Tolerability, and Efficacy…
rozanolixizumab Myasthénie Phase 3 COMPLETED En attente / non publié UCB Biopharma SRL United States, Canada, Czechia, Denmark, France, Germ… 2019-10-29 → 2021-09-01 Ouvrir
NCT03971422
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patient…
rozanolixizumab Myasthénie Phase 3 COMPLETED En attente / non publié UCB Biopharma SRL United States, Belgium, Canada, Czechia, Denmark, Fra… 2019-06-03 → 2021-10-26 Ouvrir
NCT04650854
A Study to Evaluate Rozanolixizumab in Study Participants With Generali…
rozanolixizumab Myasthénie Phase 3 COMPLETED En attente / non publié UCB Biopharma SRL United States, Canada, Czechia, Denmark, France, Geor… 2021-02-03 → 2024-01-25 Ouvrir
NCT07787247
ROME-MG — Feasibility of Remote Monitoring of Patients With Myasthenia …
ROME-MG — Feasibility of Remote M… Myasthénie À vérifier RECRUITING En attente / non publié George Washington University United States · The George Washington University, Was… 2026-08-19 → 2028-10 Ouvrir
NCT06158815
Investigation of the Effects of Proprioceptive Neuromuscular Facilitati…
Investigation of the Effects of P… Myasthénie Non applicable COMPLETED En attente / non publié Hacettepe University Turkey (Türkiye) · Hacettepe University Faculty of Ph… 2023-11-23 → 2024-12-25 Ouvrir
NCT07217509
PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness …
PPDTM CorEvitasTM Myasthenia Grav… Myasthénie À vérifier ENROLLING_BY_INVITATION En attente / non publié CorEvitas United States · CorEvitas, LLC, Waltham, United States 2025-08-14 → 2099-12-31 Ouvrir
NCT07215949
Zilucoplan for Severe gMG Exacerbations
Zilucoplan® Myasthénie Phase 3 RECRUITING En attente / non publié Miriam Freimer United States · The Ohio State University, Columbus, … 2026-01-20 → 2028-04-01 Ouvrir
NCT07647510
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Mya…
Claseprubart Myasthénie Phase 3 RECRUITING En attente / non publié Dianthus Therapeutics United States · Cinical Study Site, Boca Raton, Unite… 2026-06-29 → 2031-09 Ouvrir
NCT06149559
roMyG — A Study of Rozanolixizumab in Pediatric Study Participants With…
rozanolixizumab Myasthénie Phase 2/3 ACTIVE_NOT_RECRUITING En attente / non publié UCB Biopharma SRL Italy, Japan, Poland, Turkey (Türkiye) · Mg0006 20339… 2024-06-14 → 2026-10-05 Ouvrir
NCT07766980
Evaluating VM100 Nutritional Supplement for Improving Quality of Life i…
Evaluating VM100 Nutritional Supp… Myopathies Non applicable RECRUITING En attente / non publié University of Florida United States · University of Florida, Gainesville, U… 2026-07-27 → 2028-12 Ouvrir
NCT04587908
A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy…
TAS-205 [Ambulatory Cohort] [Non-… Myopathies Phase 3 COMPLETED En attente / non publié Taiho Pharmaceutical Co., Ltd. Japan · A site selected by Taiho Pharmaceutical Co., … 2020-11-01 → 2026-06-18 Ouvrir